NCT00549978View on ClinicalTrials.gov

Safety and Pharmacokinetics of Probucol and Cilostazol

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

August 31, 2008

Conditions
Healthy
Interventions
DRUG

Cilostazol

cilostazol, then cilostazol/probucol

DRUG

Probucol

Probucol probucol/ cilostazol

Trial Locations (1)

110-744

Clinical Trial Center, Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

NCT00549978 - Safety and Pharmacokinetics of Probucol and Cilostazol | Biotech Hunter | Biotech Hunter